Concepedia

Mirna McDonald

MM

Statistics

Publications

10

Citations

653

H-Index

10

Active since

1964

Affiliations

Teva Pharmaceuticals (United States)(Current)

Purdue Pharma (United States)

Johannes Gutenberg University Mainz

University of Colorado Denver

University Medical Center of the Johannes Gutenberg University Mainz

Mirna McDonald is an author at Teva Pharmaceuticals (United States) specializing in pharmacotherapy, clinical pharmacology, and pharmacology.

Publications per year

1964–2020

10

Publications

10

Congenital anomalies in the newborn infant, including minor variations

Philip M. Marden, David W. Smith, Mirna McDonald · Nursing Research · 1964 · 177 citations

, , +16

Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor

JHM Schellens, G.J. Creemers, Hilde Rosing et al. · British Journal of Cancer · 1996 · 130 citations · Full text

, , +11

Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps

Steven F. Weinstein, Rohit Katial, Philip G. Bardin et al. · The Journal of Allergy and Clinical Immunology In Practice · 2018 · 88 citations

, , +17

Acute selenium poisoning: case report.

Ian Civil, Mirna McDonald · PubMed · 1978 · 54 citations

, , +10

The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post‐Hoc Analyses on the First 3 Weeks of Treatment

Stephen D. Silberstein, Alan M. Rapoport, Pippa S. Loupe et al. · Headache The Journal of Head and Face Pain · 2018 · 47 citations

, , +16

1–5 of 10